PSMA I&T

P005
Grade:
GMP product
Tested for sterility and bacterial endotoxins
Description:
Chemical precursor for ¹⁷⁷Lu-PSMA-I&T.
Used in radioligand therapy for metastatic castration-resistant prostate cancer.
Synonyms:
DOTAGA-(I-y)fk (Sub-KuE)
Molar weight:
1498.4 g/mol (net peptide)
Molecular formula:
C₆₃H₉₂IN₁₁O₂₃ (net peptide)
CAS №:
2192281-54-0
PubChem CID:
146610216
Retest date:
Not less than 18 months from the manufacturing date
Packaging:
2R/4ml or 8R/10ml Type I glass vials with bromobutyl rubber stoppers
Storage conditions:
–20 ±5 °C
Transportation at 2–8 °C (less than 1 month)
Available quantities:
0.1 mg; 1.0 mg; custom quantity upon request

Quality parameters

Quality parameters

Appearance: White solid
Identification:
– HPLC: Retention time of main peak corresponds to PSMA I&T standard
– Mass spectrometry: m/z = 1498.4 ± 4
Residual heavy metals (ICP-OES): ≤ 100 ppm
Purity (HPLC): ≥ 98.0%
Bacterial endotoxins (gel-clot method): ≤ 10.0 EU/vial
Sterility (direct inoculation method): Sterile (passes test)
Sterility tests are performed for sterile products, made in aseptic conditions (class A).
Other products